203 related articles for article (PubMed ID: 2898859)
1. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
Feghali JG; Kaufman PL; Radius RL; Mandell AI
Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
[TBL] [Abstract][Full Text] [Related]
2. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
[TBL] [Abstract][Full Text] [Related]
3. A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma.
Allen RC; Hertzmark E; Walker AM; Epstein DL
Am J Ophthalmol; 1986 May; 101(5):535-41. PubMed ID: 3518464
[TBL] [Abstract][Full Text] [Related]
4. Betaxolol vs timolol. A six-month double-blind comparison.
Stewart RH; Kimbrough RL; Ward RL
Arch Ophthalmol; 1986 Jan; 104(1):46-8. PubMed ID: 3510612
[TBL] [Abstract][Full Text] [Related]
5. Betaxolol and timolol. A comparison of efficacy and side effects.
Berry DP; Van Buskirk EM; Shields MB
Arch Ophthalmol; 1984 Jan; 102(1):42-5. PubMed ID: 6367723
[TBL] [Abstract][Full Text] [Related]
6. Changing therapy from timolol to betaxolol. Effect on intraocular pressure in selected patients with glaucoma. Timolol-Betaxolol Study Group.
Vogel R; Tipping R; Kulaga SF; Clineschmidt CM
Arch Ophthalmol; 1989 Sep; 107(9):1303-7. PubMed ID: 2571326
[TBL] [Abstract][Full Text] [Related]
7. Celiprolol versus timolol and placebo: a two week double-blind comparison.
Elman J; Caprioli J; Rosanelli EG; Shields R; Mead A; Sears M; Petillo J
J Ocul Pharmacol; 1987; 3(1):5-10. PubMed ID: 2903202
[TBL] [Abstract][Full Text] [Related]
8. Additive effect of betaxolol and epinephrine in primary open angle glaucoma.
Allen RC; Epstein DL
Arch Ophthalmol; 1986 Aug; 104(8):1178-84. PubMed ID: 2874783
[TBL] [Abstract][Full Text] [Related]
9. Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow.
Rainer G; Dorner GT; Garhöfer G; Vass C; Pfleger T; Schmetterer L
Ophthalmologica; 2003; 217(4):288-93. PubMed ID: 12792136
[TBL] [Abstract][Full Text] [Related]
10. Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol.
Evans DW; Harris A; Cantor LB
J Ocul Pharmacol Ther; 1999 Dec; 15(6):479-87. PubMed ID: 10609770
[TBL] [Abstract][Full Text] [Related]
11. [Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
Pecori-Giraldi J; Collini S; Planner-Terzaghi A; Arrico L; Grechi G
Fortschr Ophthalmol; 1988; 85(3):235-8. PubMed ID: 2905321
[No Abstract] [Full Text] [Related]
12. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
13. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension.
Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S
Arzneimittelforschung; 2006; 56(11):729-34. PubMed ID: 17220049
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
[TBL] [Abstract][Full Text] [Related]
15. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
Camras CB
Ophthalmology; 1996 Jan; 103(1):138-47. PubMed ID: 8628544
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases].
Bleckmann H; Dorow P
Klin Monbl Augenheilkd; 1987 Sep; 191(3):199-202. PubMed ID: 2890791
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ophthalmic beta-blocking agents.
Lesar TS
Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
Kendall K; Mundorf T; Nardin G; Zimmerman TJ; Hesse R; Lavin P
Clin Ther; 1987; 9(6):651-5. PubMed ID: 2894245
[TBL] [Abstract][Full Text] [Related]
19. Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol.
Lynch MG; Whitson JT; Brown RH; Nguyen H; Drake MM
Arch Ophthalmol; 1988 Jul; 106(7):908-11. PubMed ID: 2898932
[TBL] [Abstract][Full Text] [Related]
20. Decreased intraocular pressure in the hypertensive human eye with betaxolol, a beta 1-adrenergic antagonist.
Feghali JG; Kaufman PL
Am J Ophthalmol; 1985 Dec; 100(6):777-82. PubMed ID: 2866715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
